FINGERT HJ[au] - Search Results

Year	Number of Results
1984	3
1986	1
1987	1
1988	1
1989	2
1991	1
1993	2
1994	3
2004	1
2006	1
2007	2
2008	1
2009	1
2017	1
2018	1
2026	0

1

Drug-induced QTc interval prolongation: a proposal towards an efficient and safe anticancer drug development.

Curigliano G, Spitaleri G, Fingert HJ, de Braud F, Sessa C, Loh E, Cipolla C, De Pas T, Goldhirsch A, Shah R. Curigliano G, et al. Among authors: fingert hj. Eur J Cancer. 2008 Mar;44(4):494-500. doi: 10.1016/j.ejca.2007.10.001. Epub 2007 Nov 19. Eur J Cancer. 2008. PMID: 18024014 Review.

2

Assessing proarrhythmic potential of drugs when optimal studies are infeasible.

Rock EP, Finkle J, Fingert HJ, Booth BP, Garnett CE, Grant S, Justice RL, Kovacs RJ, Kowey PR, Rodriguez I, Sanhai WR, Strnadova C, Targum SL, Tsong Y, Uhl K, Stockbridge N. Rock EP, et al. Among authors: fingert hj. Am Heart J. 2009 May;157(5):827-36, 836.e1. doi: 10.1016/j.ahj.2009.02.020. Am Heart J. 2009. PMID: 19376308 Review.

3

Cardiac safety, risk management, and oncology drug development.

Fingert HJ, Varterasian ML. Fingert HJ, et al. Clin Cancer Res. 2006 Jun 15;12(12):3646-7. doi: 10.1158/1078-0432.CCR-06-0518. Clin Cancer Res. 2006. PMID: 16778090 No abstract available.

4

Expanding Role of Data Science and Bioinformatics in Drug Discovery and Development.

Fingert HJ. Fingert HJ. Clin Pharmacol Ther. 2018 Jan;103(1):47-49. doi: 10.1002/cpt.912. Epub 2017 Nov 14. Clin Pharmacol Ther. 2018. PMID: 29134636

5

Megadose chemotherapy with bone marrow rescue.

Fingert HJ, Hochberg FH. Fingert HJ, et al. Prog Exp Tumor Res. 1984;28:67-78. doi: 10.1159/000408238. Prog Exp Tumor Res. 1984. PMID: 6385130 No abstract available.

6

Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).

Panosyan EH, Grigoryan RS, Avramis IA, Seibel NL, Gaynon PS, Siegel SE, Fingert HJ, Avramis VI. Panosyan EH, et al. Among authors: fingert hj. Anticancer Res. 2004 Mar-Apr;24(2C):1121-5. Anticancer Res. 2004. PMID: 15154634 Free article.

7

Incapacitating autonomic neuropathy precipitated by taxol.

Jerian SM, Sarosy GA, Link CJ Jr, Fingert HJ, Reed E, Kohn EC. Jerian SM, et al. Among authors: fingert hj. Gynecol Oncol. 1993 Nov;51(2):277-80. doi: 10.1006/gyno.1993.1287. Gynecol Oncol. 1993. PMID: 7903950

8

In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.

Mosseri M, Fingert HJ, Varticovski L, Chokshi S, Isner JM. Mosseri M, et al. Among authors: fingert hj. Cancer Res. 1993 Jul 1;53(13):3028-33. Cancer Res. 1993. PMID: 8391384

9

Cyclin E, a potential prognostic marker for breast cancer.

Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Keyomarsi K, et al. Among authors: fingert hj. Cancer Res. 1994 Jan 15;54(2):380-5. Cancer Res. 1994. PMID: 7903908

10

The fluorescent cytoprint assay in gynecological malignancies and breast cancer. Methodology and results.

Blackman KE, Fingert HJ, Fuller AF, Meitner PA. Blackman KE, et al. Among authors: fingert hj. Contrib Gynecol Obstet. 1994;19:53-63. Contrib Gynecol Obstet. 1994. PMID: 7995053 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year